Professor Mike Catchpole, Chief Scientist of ECDC, presented to the Environment, Public Health and Food Safety Committee of the European Parliament during an exchange of views on vaccination.
At this technical meeting, tuberculosis experts from high-incidence countries (Bulgaria, Estonia, Latvia, Lithuania and Romania) discussed ways in which ECDC can support with development and implementation of country strategies to prevent and control the disease.
High-level meeting to discuss the burden of TB and MDR TB and its elimination as a public health problem in the EU/EEA and Eastern Partnership countries.
Neuraminidase inhibitors, commonly referred to as antivirals, have been subject to much debate about the effectiveness in preventing and treating influenza. ECDC convened a meeting of experts in order to review and discuss evidence regarding antivirals.
Kick-off meeting and large capacity building workshop of the ERLTB-Net. The meeting was a place for information exchange, networking, analysis of ERLN-TB achievements and planning of future initiatives.
WHO/Europe has been holding annual influenza surveillance meetings jointly with the European Centre for Disease Prevention and Control (ECDC) since 2011. This meeting brought together epidemiologists and virologists – the national influenza surveillance focal points – from 50 Member States to discuss national, regional and global surveillance related to seasonal influenza and novel influenza viruses, such as avian influenza A(H7N9).
Every other year EU/EEA representatives meet to discuss the specifics of surveillance in the EU/EEA. The aim is to discuss TB epidemiology and progress towards elimination in Europe.
The objective for this meeting between ECDC and influenza vaccine manufacturers was to share latest information on influenza disease monitoring including severe disease, monitoring of seasonal influenza vaccination programmes in the EU and new technical developments for improved influenza vaccines.